Article Listing - Patients more likely to stay on Pfizer's Lipitor than simvastatin, says managed care database study

VOLUME GROWTH FOR US DRUGMAKERS

9 March 1992

The US pharmaceutical industry in general shows particularly impressive unit growth characteristics, according to Steven Gerber of New York securities...

FDA MOVE UPGRADES BIOCRAFT EARNINGS

9 March 1992

Biocraft stock has been upgraded from a hold to a buy on the news that the US Food and Drug...

GERMAN PHARMACY MARGINS ROW

9 March 1992

The German pharmacists' federation, the BVDA, has rejected criticisms of fixed pharmacy and wholesale margins made by the industrial health...

POLAND REIMPOSES DUTY ON IMPORTS

9 March 1992

The Polish Customs Office has introduced a 10% duty on drugs and medicines brought into the country from abroad, to...

BARR LABS 2nd QTR NET INCOME DOWN

9 March 1992

Barr Laboratories in the USA made sales for the second quarter ended December 31, 1991 of $30.6 million, up 18.6%...

BIOCRAFT LABS MAKES 3rd QTR LOSS

9 March 1992

US concern Biocraft Laboratories made sales for the third quarter ended December 31, 1991, of $24.2 million, up 16.7% on...

EURO MARKET FOR DRUG INTERMEDIATES

9 March 1992

The western European market for high-value pharmaceutical intermediates will grow from $565 million in 1991 to $678 million by 1996,...

FORTHCOMING MEETINGS

9 March 1992

Among Management Forum's meetings to be held in London in March are Over-The-Counter Medicines (Conf No E3-17), March 24 and...

STOCK MARKET COMMENTARY: EUROPE

9 March 1992

EUROPE: ended the reporting week with upturns in Belgium, Sweden, Germany and Switzerland, but declines or stagnation of the market...

W E HAUCK ACQUISITION

9 March 1992

Roberts Pharmaceutical has completed the acquisition of W E Hauck in the USA for $7 million.

Showing 94721-94730 of 95372 articles